Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Therapeutic Use of Estrogen Receptor β Agonists in Prevention and Treatment of Endocrine Therapy Resistant Breast Cancers: Observations From Preclinical Models.

Ramasamy K, Samayoa C, Krishnegowda N, Tekmal RR.

Prog Mol Biol Transl Sci. 2017;151:177-194. doi: 10.1016/bs.pmbts.2017.08.002. Epub 2017 Oct 6. Review.

PMID:
29096893
2.

Clinical and Pathologic Features of Hispanic Endometrial Cancer Patients With Loss of Mismatch Repair Expression.

Kost ER, Valente PT, Lynch BA, Krishnegowda NK, Hertz AM, Hall KL, Riddle ND, Tekmal RR.

Int J Gynecol Cancer. 2016 Jul;26(6):1129-36. doi: 10.1097/IGC.0000000000000713.

PMID:
27327152
3.

Effects of Combination of Estradiol with Selective Progesterone Receptor Modulators (SPRMs) on Human Breast Cancer Cells In Vitro and In Vivo.

Nair HB, Santhamma B, Krishnegowda NK, Dileep KV, Nickisch KJ.

PLoS One. 2016 Mar 24;11(3):e0151182. doi: 10.1371/journal.pone.0151182. eCollection 2016.

4.

Impaired Development of Early Endometriotic Lesions in CD44 Knockout Mice.

Knudtson JF, Tekmal RR, Santos MT, Binkley PA, Krishnegowda N, Valente P, Schenken RS.

Reprod Sci. 2016 Jan;23(1):87-91. doi: 10.1177/1933719115594022. Epub 2015 Jul 12.

PMID:
26169039
5.

Differentiated adipose-derived stem cell cocultures for bone regeneration in polymer scaffolds in vivo.

Shah AR, Cornejo A, Guda T, Sahar DE, Stephenson SM, Chang S, Krishnegowda NK, Sharma R, Wang HT.

J Craniofac Surg. 2014 Jul;25(4):1504-9. doi: 10.1097/SCS.0000000000000755.

PMID:
24943502
6.

Gossypin as a novel selective dual inhibitor of V-RAF murine sarcoma viral oncogene homolog B1 and cyclin-dependent kinase 4 for melanoma.

Bhaskaran S, Dileep KV, Deepa SS, Sadasivan C, Klausner M, Krishnegowda NK, Tekmal RR, VandeBerg JL, Nair HB.

Mol Cancer Ther. 2013 Apr;12(4):361-72. doi: 10.1158/1535-7163.MCT-12-0965. Epub 2013 Mar 29.

7.

Effect of endothelial differentiated adipose-derived stem cells on vascularity and osteogenesis in poly(D,L-lactide) scaffolds in vivo.

Sahar DE, Walker JA, Wang HT, Stephenson SM, Shah AR, Krishnegowda NK, Wenke JC.

J Craniofac Surg. 2012 May;23(3):913-8. doi: 10.1097/SCS.0b013e31824e5cd8.

PMID:
22627404
8.

Raf-1, a potential therapeutic target, mediates early steps in endometriosis lesion development by endometrial epithelial and stromal cells.

De La Garza EM, Binkley PA, Ganapathy M, Krishnegowda NK, Tekmal RR, Schenken RS, Kirma NB.

Endocrinology. 2012 Aug;153(8):3911-21. doi: 10.1210/en.2011-1879. Epub 2012 May 22.

PMID:
22619359
9.

Effect of adipose tissue-derived osteogenic and endothelial cells on bone allograft osteogenesis and vascularization in critical-sized calvarial defects.

Cornejo A, Sahar DE, Stephenson SM, Chang S, Nguyen S, Guda T, Wenke JC, Vasquez A, Michalek JE, Sharma R, Krishnegowda NK, Wang HT.

Tissue Eng Part A. 2012 Aug;18(15-16):1552-61. doi: 10.1089/ten.TEA.2011.0515. Epub 2012 May 10.

PMID:
22440012
10.

Estrogen receptor-beta mediates the protective effects of aromatase induction in the MMTV-Her-2/neu x aromatase double transgenic mice.

Nair HB, Perla RP, Kirma NB, Krishnegowda NK, Ganapathy M, Rajhans R, Nair SS, Saikumar P, Vadlamudi RK, Tekmal RR.

Horm Cancer. 2012 Apr;3(1-2):26-36. doi: 10.1007/s12672-011-0083-5.

PMID:
22006184
11.

Novel function of transcription factor Nrf2 as an inhibitor of RON tyrosine kinase receptor-mediated cancer cell invasion.

Thangasamy A, Rogge J, Krishnegowda NK, Freeman JW, Ammanamanchi S.

J Biol Chem. 2011 Sep 16;286(37):32115-22. doi: 10.1074/jbc.M111.245746. Epub 2011 Jul 28.

12.

Immunologic parameters during NOTES compared with laparoscopy in a randomized blinded porcine trial.

Bingener J, Krishnegowda NK, Michalek JE.

Surg Endosc. 2009 Jan;23(1):178-81. doi: 10.1007/s00464-008-0162-z. Epub 2008 Sep 24.

PMID:
18813979
13.

Flavonoid, silibinin, inhibits proliferation and promotes cell-cycle arrest of human colon cancer.

Hogan FS, Krishnegowda NK, Mikhailova M, Kahlenberg MS.

J Surg Res. 2007 Nov;143(1):58-65.

PMID:
17950073
14.

Determining risk of biochemical recurrence in prostate cancer by immunohistochemical detection of PTEN expression and Akt activation.

Bedolla R, Prihoda TJ, Kreisberg JI, Malik SN, Krishnegowda NK, Troyer DA, Ghosh PM.

Clin Cancer Res. 2007 Jul 1;13(13):3860-7.

15.

Compensatory increases in Her-2/neu activation in response to EGFR tyrosine kinase inhibition in colon cancer cell lines.

Learn PA, Krishnegowda N, Talamantez J, Kahlenberg MS.

J Surg Res. 2006 Dec;136(2):227-31. Epub 2006 Oct 23.

PMID:
17059835
16.

Knockdown of prothrombin in zebrafish.

Day K, Krishnegowda N, Jagadeeswaran P.

Blood Cells Mol Dis. 2004 Jan-Feb;32(1):191-8.

PMID:
14757435

Supplemental Content

Loading ...
Support Center